2024 Rome, Italy

III-097 Christelle Rodrigues
Optimizing the Dose Escalation of a new anti-CD73 monoclonal antibody for target Inhibition: A Comprehensive Preclinical and Clinical Modelling Approach
Thursday 09:50-11:20